Profound Medical Q1 2026 Earnings Call
Analysis based on 8 articles · First reported Apr 16, 2026 · Last updated Apr 16, 2026
The market impact is primarily on Profound Medical Corp. as investors will react to the announced first quarter 2026 financial results. The broader market impact is minimal, as this is a routine earnings announcement for a single company.
Profound Medical Corp., a commercial-stage medical device company, announced that it will release its first quarter 2026 financial results after market close on Thursday, May 7, 2026. Following the announcement, Profound Medical Corp. management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments. The company specializes in AI-powered, MRI-guided, incision-free therapies for diseased tissue, with flagship platforms TULSA-PRO and Sonalleve approved in major global markets.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard